Barclays Reports 18 Profit Rise Raises FullYear Income Guidance Burberry Shares Climb on Speculation of Potential Moncler Takeover Bid Cave Rescue Incident Raises Questions on Diving Equipment Standards Feds Waller Joins Policymakers Signaling Potential Rate Hike as Next Move Bull Market Longevity Question How Long Can the Rally Persist Gas Price Outlook Brace for Most Volatile Summer in Years Experts Say Marriott Vacations Worldwide VAC Q1 2026 Earnings EPS Misses Estimates as Stock Edges Higher GERN Q1 2026 Earnings NarrowerthanExpected Loss Fuels Investor Optimism SU Q1 2026 Earnings Strong EPS Beat Highlights Operational Efficiency Amid Market Challenges Arvinas ARVN Q1 2026 Earnings Narrower Loss Beats Estimates Amid Pipeline Progress Kadant Inc KAI Q1 2026 Earnings Strong EPS Beat Despite Revenue Uncertainty First Interstate BancSystem Inc FIBK Q1 2026 Earnings EPS Misses Estimates Amid Margin Pressure Japer Therapeutics Warrants JSPRW Flat at Penny Level Amid Minimal Activity XFLH Capital Corporation XFLH Holds Steady at 1022 as Key Levels Define Trading Range Trinity Capital Inc Notes TRINI Hold Steady Near Par Amid Stable Credit Conditions PAXS Edges Lower but Holds Above Key Support Level Sensata Technologies ST Surges 37 as Stock Approaches Key Resistance OECD Consumer Price Data Update Signals Persistent Inflation Trends FENC Q1 2026 Earnings Unexpected Profitability Surprises Market Stock Edges Lower Solitario Resources XPL Slips 167 as Consolidation Continues Near Key Support SEC Advances TrumpBacked Proposal to End Mandatory Quarterly Earnings Reports Bessent Anticipates Substantial Disinflation as Warsh Assumes Federal Reserve Leadership Oppenheimer Upgrades Outlook on Marvell Technology With Price Target Boost Indian Stock Market Outlook Sensex and Nifty 50 Set to Navigate USIran Tensions Next Week Spencer Pratts Social Media Strategy Could Reshape Political Campaigning But Can It Win LA Mayoral Race Wall Street Slips as Industrial Drag Offsets Healthcare and Energy Gains Traders Bet on IonQ Micron Anduril as Next Potential Government Stake Targets